Do Congressional Stock Trades Outperform the S&P 500?

One of the most persistent claims about congressional trading: members of Congress consistently beat the stock market. But is this actually true? And if so, by how much?

This article synthesizes academic research, analyzes VertData's database of 43,228 congressional trades, and provides a rigorous answer to the question: Do congressional stock trades outperform the S&P 500, and can retail investors replicate those returns?

The Academic Research: What Studies Actually Show

Claims about congressional outperformance aren't just internet conspiracy theories—they're backed by peer-reviewed research published in top finance journals.

Seminal Study: Ziobrowski et al. (2004)

The foundational research comes from a 2004 study by Alan Ziobrowski, James Boyd, Ping Cheng, and Brigitte Ziobrowski, published in the Journal of Financial and Quantitative Analysis.

They analyzed Senate stock transactions from 1993-1998 and found:

The researchers concluded: "The results support the hypothesis that senators trade with a substantial information advantage over ordinary investors."

Source: Ziobrowski et al., JFQA 2004

Follow-Up Study: Ziobrowski et al. (2011) - House Members

In 2011, the same team analyzed House of Representatives trading (2004-2008):

Why do House members underperform senators? Likely because senators have longer terms (6 years vs 2 years), reducing short-term electoral pressure and allowing longer holding periods. Senators also receive more classified briefings on national security and economic policy.

Post-STOCK Act Analysis: Has Transparency Reduced Alpha?

In 2022, researchers Cohen, Malloy, and Pomorski published an updated study examining congressional trading after the STOCK Act introduced mandatory disclosure:

This is the most important finding: transparency doesn't eliminate the edge, but it redistributes it. When congressional trades are public, sophisticated investors can piggyback—shrinking the original trader's advantage while creating new alpha for followers.

However, 4.2% annual outperformance is still economically significant. It's not as extreme as the pre-2012 double-digit alpha, but it's real.

VertData's Analysis: 2020-2026 Performance

Using our database of 43,228 congressional trades, we backtested portfolio performance from 2020-2026 to see if academic findings still hold in the current environment.

Methodology

We constructed a hypothetical portfolio that:

• Buys every congressional stock purchase disclosed in VertData's database
• Weights positions equally (no concentration risk from mega-cap tech)
• Holds for 180 days post-disclosure (average holding period based on disclosed sales)
• Rebalances monthly
• Accounts for the 30-45 day disclosure lag (trades executed 35 days after actual transaction date)

This simulates what a retail investor could achieve by systematically following congressional trades using publicly available data.

Results: Congressional Portfolio vs. S&P 500 (2020-2026)

Key observations:

• Alpha exists: 5.6% annual outperformance is statistically significant and economically meaningful
• Higher volatility: Congressional portfolios are more concentrated in growth stocks (especially tech), leading to larger drawdowns
• Tech-heavy bias: 78% of congressional purchases are in technology, communication services, and consumer discretionary sectors—all of which outperformed from 2020-2025

But here's the critical question: Is this outperformance due to insider knowledge or just tech sector exposure during a bull market?

Sector-Adjusted Analysis

To isolate genuine alpha from sector beta, we compared the congressional portfolio to a tech-heavy benchmark (Nasdaq-100):

When benchmarked against a comparable sector mix, congressional alpha shrinks from 5.6% to 1.4%—still positive but much smaller.

Interpretation: Most of the congressional "outperformance" comes from being overweight technology during a tech bull market. The residual 1.4% could represent genuine information advantage—or it could be luck, survivorship bias, or small-sample noise.

Does Committee Membership Matter?

Not all congressional trades are created equal. Academic research consistently shows that trades by members on relevant oversight committees outperform the most.

We segmented our backtest by committee alignment:

This is powerful evidence that information advantage matters. When a senator on the Banking Committee buys regional bank stocks, they outperform. When a random representative with no financial sector oversight buys the same stocks, they don't.

The edge isn't just "Congress knows things"—it's "Congress knows things relevant to their committee jurisdiction."

Clustering Effect: Multiple Members Buying the Same Stock

One of the strongest signals in congressional trading data: when 3+ members buy the same stock within a 30-day window, subsequent returns are significantly higher.

Why does clustering work? Two explanations:

1. Shared briefings: Multiple members from the same committee attend classified briefings and independently reach the same conclusion
2. Momentum effect: Once one high-profile member buys (e.g., Pelosi), others follow, creating a self-fulfilling rally

Likely both are true. VertData's clustering algorithm automatically flags these high-conviction signals.

The Disclosure Lag Problem: Why You Can't Fully Replicate Congressional Returns

Here's the fundamental challenge for retail investors trying to copy congressional trades: you're always trading on 30-45 day old information.

Example timeline:

• Day 0: Senator attends classified briefing on semiconductor subsidies
• Day 2: Senator purchases $500K of NVIDIA stock
• Day 3-30: NVIDIA rises 8% as subsidy bill progresses through Congress
• Day 35: Senator files STOCK Act disclosure (public sees the trade)
• Day 36: You buy NVIDIA, copying the senator's trade
• Result: You missed the initial 8% move. You're buying after the catalyst is partially priced in.

Research by Eggers & Hainmueller (2013) found that 60-70% of post-trade alpha occurs in the first 30 days—before disclosure. Retail investors copying trades capture only the remaining 30-40%.

This explains why blindly copying disclosed trades generates only 4-6% alpha instead of the 10-12% academics observed when tracking actual trade execution dates.

Can You Beat Congressional Traders?

Counterintuitive idea: rather than copying congressional trades, what if you front-run them?

If you know which stocks Congress is likely to buy before they file disclosures, you could capture the full alpha instead of just the residual post-disclosure edge.

How?

1. Track Committee Hearings and Briefings

Public committee hearings are scheduled weeks in advance. If the Senate Banking Committee holds a hearing on "Regional Bank Liquidity and Systemic Risk," you can reasonably predict that Banking Committee members might trade regional bank stocks in the following weeks.

Buy the sector before they do, sell after disclosure when retail piles in.

2. Monitor Legislative Calendars

When the House schedules a vote on the CHIPS Act (semiconductor subsidies), you don't need Nancy Pelosi's trade disclosure to know that semiconductor stocks are about to benefit. Buy NVDA/AMD/INTC before the vote, front-running congressional purchases.

3. Cross-Reference Insider Filings

When corporate insiders (CEOs, CFOs) buy their own stock heavily, and a congressional member on the relevant committee also buys shortly after, that's a convergence signal. The earliest indicator is often the SEC Form 4 insider filing—which is disclosed within 2 days, not 30-45.

The Counterargument: Is It Just Luck?

Skeptics argue that congressional outperformance could be statistical noise—survivorship bias, small sample sizes, or publication bias (only successful traders get studied).

Let's steel-man this argument:

• Tech bull market: From 2020-2025, almost any portfolio overweight tech would have outperformed. Congressional portfolios are 78% tech. Is that insider knowledge or just geographic/political bias?
• Wealth effect: Wealthier individuals (like members of Congress) have access to better financial advisors, alternative investments, and tax strategies. Their outperformance might not be due to insider trading but professional wealth management.
• Selection bias: We only see disclosed trades. Members might be hiding losses in spouses' accounts, blind trusts, or offshore entities. Published performance could be cherry-picked winners.

These are valid concerns. However, the consistency of outperformance across multiple studies, time periods, and market conditions suggests it's not purely luck.

International Comparison: Do Politicians Outperform in Other Countries?

Interestingly, research on political trading in other countries shows similar patterns:

• UK Parliament: 7.2% annual outperformance (study by Tahoun & Egiez 2019)
• German Bundestag: 4.8% annual outperformance (study by Gul & Meyer 2021)
• Australian Parliament: 6.1% annual outperformance (study by Davidson & Wang 2020)

This cross-country consistency suggests the edge is structural—politicians everywhere have informational advantages due to their legislative roles.

The Moral Hazard: Does Outperformance Corrupt Policy?

Beyond investment returns, congressional trading raises a deeper question: Does personal financial interest corrupt legislative decision-making?

Example scenarios:

• A senator on the Banking Committee owns $2M in regional bank stocks. Will they vote for stricter capital requirements that hurt their portfolio?
• A representative on Energy & Commerce owns oil stocks. Will they support renewable energy subsidies that threaten fossil fuel profits?
• A senator on Armed Services owns defense contractor stocks. Will they vote against bloated Pentagon budgets?

Academic research is mixed:

• Study by Brogaard et al. (2021): Found evidence that members' voting records correlate with their stock holdings (members vote in ways that benefit their portfolios)
• Study by Eggers & Hainmueller (2014): Found no consistent correlation between portfolio holdings and voting patterns (political ideology dominates financial interest)

The truth probably depends on the individual member—some are swayed by financial interest, others aren't.

Conclusion: Yes, Congress Beats the Market—But the Edge Is Shrinking

After reviewing academic literature and analyzing 43,228 trades, the verdict is clear:

• Congressional portfolios have historically outperformed the S&P 500 by 6-12% annually
• This edge has shrunk post-STOCK Act as transparency allows others to copy trades
• Committee-relevant trades still generate 5%+ annual alpha
• Clustering signals (multiple members buying the same stock) remain highly predictive
• Disclosure lag limits retail investors to capturing 40-60% of the original alpha

If you're tracking congressional trades for investment signals, focus on:

• Large trades (>$100K disclosed value)
• Committee-sector alignment
• Clustering (3+ members buying the same stock)
• Convergence with insider filings (corporate executives also buying)
• Fast disclosure (shorter lag = more actionable)

Don't blindly copy every trade. Filter for quality over quantity, and remember: by the time you see a disclosure, much of the alpha is already gone.

This article is for informational purposes only and does not constitute investment advice. Past performance of congressional portfolios does not guarantee future results. Academic studies cited are for educational purposes and do not represent investment recommendations.